Rate My Professor Josh Davis

Professor Davis's research specializations focus on clinical trials in severe infectious diseases, including management of Staphylococcus aureus bloodstream infections, bone and joint infections, severe sepsis, viral hepatitis, Aboriginal health, and adaptive platform trials such as Bayesian designs. He has authored over 220 peer-reviewed publications, garnering more than 14,300 citations with an h-index of 51. Key publications include "Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management" (Clinical Microbiology Reviews, 2015) and "Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial" (Clinical Infectious Diseases, 2016). His achievements include the NHMRC Research Excellence Award for the top-ranked CDF2 application nationally (2019), the Fenner Award for Advanced Research in Infectious Diseases (2021) from the Australasian Society for Infectious Diseases (past president), and chief investigator roles on NHMRC/MRFF grants exceeding $52 million. As founding director and current deputy director of the HMRI Infection Research Program, and leader of trials like SNAP for S. aureus infections and ROADMAP for prosthetic joint infections, he has significantly impacted the field through innovative clinical research and trial design.